Gut Microbiota and Atherosclerosis-Focusing on the Plaque Stability

被引:43
作者
Shen, Xinyi [1 ]
Li, Lihua [2 ]
Sun, Zhen [1 ]
Zang, Guangyao [1 ]
Zhang, Lili [1 ]
Shao, Chen [1 ]
Wang, Zhongqun [1 ]
机构
[1] Jiangsu Univ, Dept Cardiol, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China
[2] Jiangsu Univ, Affiliated Hosp, Dept Pathol, Zhenjiang, Jiangsu, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2021年 / 8卷
基金
中国国家自然科学基金;
关键词
atherosclerosis; metabolites; therapies; plaque stability; gut microbiota; CORONARY-ARTERY-DISEASE; TRIMETHYLAMINE-N-OXIDE; LIPOPOLYSACCHARIDE-BINDING PROTEIN; HUMAN COLONIC MICROBIOTA; CHAIN FATTY-ACIDS; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; FECAL MICROBIOTA; MUCUS BARRIER;
D O I
10.3389/fcvm.2021.668532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular diseases (CVDs) are major causes of mortality and morbidity in the modern society. The rupture of atherosclerotic plaque can induce thrombus formation, which is the main cause of acute cardiovascular events. Recently, many studies have demonstrated that there are some relationships between microbiota and atherosclerosis. In this review, we will focus on the effect of the microbiota and the microbe-derived metabolites, including trimethylamine-N-oxide (TMAO), short-chain fatty acids (SCFAs), and lipopolysaccharide (LPS), on the stability of atherosclerotic plaque. Finally, we will conclude with some therapies based on the microbiota and its metabolites.
引用
收藏
页数:15
相关论文
共 204 条
  • [11] Bibbò S, 2016, EUR REV MED PHARMACO, V20, P4742
  • [12] Dietary destabilisation of the balance between the microbiota and the colonic mucus barrier
    Birchenough, George
    Schroeder, Bjoern O.
    Backhed, Fredrik
    Hansson, Gunnar C.
    [J]. GUT MICROBES, 2019, 10 (02) : 246 - 250
  • [13] Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection
    Boccellato, Francesco
    Woelffling, Sarah
    Imai-Matsushima, Aki
    Sanchez, Gabriela
    Goosmann, Christian
    Schmid, Monika
    Berger, Hilmar
    Morey, Pau
    Denecke, Christian
    Ordemann, Juergen
    Meyer, Thomas F.
    [J]. GUT, 2019, 68 (03) : 400 - +
  • [14] Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia
    Boroni Moreira, Ana Paula
    Salles Texeira, Tatiana Fiche
    Ferreira, Alessandra Barbosa
    Gouveia Peluzio, Maria do Carmo
    Goncalves Alfenas, Rita de Cassia
    [J]. BRITISH JOURNAL OF NUTRITION, 2012, 108 (05) : 801 - 809
  • [15] A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis
    Brandsma, Eelke
    Kloosterhuis, Niels J.
    Koster, Mirjam
    Dekker, Daphne C.
    Gijbels, Marion J. J.
    van der Velden, Saskia
    Rios-Morales, Melany
    van Faassen, Martijn J. R.
    Loreti, Marco G.
    de Bruin, Alain
    Fu, Jingyuan
    Kuipers, Folkert
    Bakker, Barbara M.
    Westerterp, Marit
    de Winther, Menno P. J.
    Hofker, Marten H.
    van de Sluis, Bart
    Koonen, Debby P. Y.
    [J]. CIRCULATION RESEARCH, 2019, 124 (01) : 94 - 100
  • [16] Differences in gut microbiota profile between women with active lifestyle and sedentary women
    Bressa, Carlo
    Bailen-Andrino, Maria
    Perez-Santiago, Jennifer
    Gonzalez-Soltero, Rocio
    Perez, Margarita
    Gregoria Montalvo-Lominchar, Maria
    Luis Mate-Munoz, Jose
    Dominguez, Raul
    Moreno, Diego
    Larrosa, Mar
    [J]. PLOS ONE, 2017, 12 (02):
  • [17] Bacterial butyrate prevents atherosclerosis
    Bultman, Scott J.
    [J]. NATURE MICROBIOLOGY, 2018, 3 (12): : 1332 - 1333
  • [18] The developing gut microbiota and its consequences for health
    Butel, M. -J.
    Waligora-Dupriet, A. -J.
    Wydau-Dematteis, S.
    [J]. JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, 2018, 9 (06) : 590 - 597
  • [19] Leaky gut: mechanisms, measurement and clinical implications in humans
    Camilleri, Michael
    [J]. GUT, 2019, 68 (08) : 1516 - 1526
  • [20] Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
    Cani, P. D.
    Possemiers, S.
    Van de Wiele, T.
    Guiot, Y.
    Everard, A.
    Rottier, O.
    Geurts, L.
    Naslain, D.
    Neyrinck, A.
    Lambert, D. M.
    Muccioli, G. G.
    Delzenne, N. M.
    [J]. GUT, 2009, 58 (08) : 1091 - 1103